Relay Therapeutics Inc expected to post a loss of 77 cents a share - Earnings Preview

Relay Therapeutics

04/11/2024 23:33

* Relay Therapeutics Inc  RLAY.OQ   RLAY.O  is expected
to show a
fall in quarterly revenue when it reports  results on November 6
for the period ending September 30 2024
    * The Cambridge Massachusetts-based  company is expected to
report
a 99.7% decrease in revenue to $80 thousand from $25.2 million a
year ago, according to the mean estimate from 10 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for Relay Therapeutics Inc
is for
a loss of 77 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 12 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Relay
Therapeutics Inc is 20.50​, above​ its last closing price
of $5.84. ​​​

This summary was machine generated November 4 at 23:33 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)